期刊文献+

全程化药学服务保障5α还原酶缺乏症患儿安全合理用药 被引量:3

Whole-process pharmaceutical care ensures safe and rational drug use in children with 5α-reductase deficiency
下载PDF
导出
摘要 目的探索临床药师对5α还原酶缺乏症(5α-RD)患儿全疗程药学服务工作方法与模式。方法临床药师加入多学科治疗团队,通过提供超说明书治疗方案依据,监测患儿阴茎增长、睾酮变化及肝功能、血脂水平、红细胞压积、血红蛋白等疗效和安全性指标,并为患儿提供互联网门诊咨询等方式,助力患儿安全有效用药。结果5α-RD患儿对药品的反应差异较大,药品对阴茎增长的促进影响不尽相同。临床药师对5α-RD患儿进行药学监护,参与疾病治疗与监测,为患儿家属答疑解惑,提高用药依从性和疗效,减少不良反应发生。结论全程化药学服务使5α-RD患儿受益,保障患儿合理安全用药。 Objective To explore the working method and mode of clinical pharmacists in the full course of pharmaceutical care for children with 5-alpha-reductase deficiency(5α-RD).Methods Clinical pharmacists joined the multidisciplinary treatment team to assist the safe and effective treatment of children by providing the treatment protocol beyond indications,monitoring the children′s penile growth,changes in testosterone,liver function,blood lipid levels,hematocrit,hemoglobin and other efficacy and safety indicators,and providing internet outpatient consultation for children.Results Exploration and practice found the response of children with 5α-reductase deficiency was significantly different.The drug had different promoting effects on penile growth.Clinical pharmacists could improve compliance and efficacy and reduce the occurrence of adverse reactions by providing pharmaceutical care to children with 5α-RD,participating in disease treatment and monitoring,and answering questions of parents of patients.Conclusion Whole-process pharmaceutical care benefits the children with 5α-reductase deficiency and ensures rational and safe drug use in children.
作者 刘莹 巩纯秀 LIU Ying;GONG Chun-xiu(Department of Pharmacy,Genetics and Metabolism,Beijing Children’s Hospital,Capital Medical University,National Center for Children′s Health,Beijing 100045,China;Department of Endocrinology,Genetics and Metabolism,Beijing Children’s Hospital,Capital Medical University,National Center for Children′s Health,Beijing 100045,China)
出处 《实用药物与临床》 CAS 2022年第9期822-825,共4页 Practical Pharmacy and Clinical Remedies
基金 首都临床诊疗技术研究及转化应用北京市科学技术委员会资助项目(Z201100005520061) 金磊儿科内分泌中青年医师成长科研基金(PEGRF201809006)。
关键词 5α还原酶缺乏症 十一酸睾酮 临床药师 全程化药学服务 5α-reductase deficiency Testosterone undecanoate Clinical pharmacist Integrated pharmaceutical care
  • 相关文献

参考文献4

二级参考文献33

  • 1刘杰.雄激素替代疗法的现在和将来[J].国外医学(药学分册),2005,32(4):259-261. 被引量:4
  • 2伍学焱,茅江峰,卢双玉,金自孟,史轶蘩.男性青少年性腺功能减退症患者短期雄激素替代治疗对血脂和hsCRP水平的影响[J].中国男科学杂志,2007,21(2):31-33. 被引量:2
  • 3Hughes IA, Hank C, Ahmed SF, et al. Consensus statement on management of intersex disorders. Arch Dis Child, 2006, 91 (7) : 554-563.
  • 4Wiesemann C, Ude-Koeller S, Sinnecker GH, et al. Ethical principles and recommendations for the medical management of differences of sex development (DSD)/intersex in children and adolescents. Eur J Pediatr, 2010, 169(6) :671-679.
  • 5Nelson CP, Park JM, Wan J, et al. The increasing incidence of congenital penile anomalies in the United States. J Urol, 2005, 174(4 Pt 2) :1573-1576.
  • 6Ishii T, Sasaki G, Hasegawa T, et al. Testosterone enanthate therapy is effective and independent of SRD5A2 and AR gene polymorphisms in boys with micropenis. J Urol, 2004, 172 (1) : 319-324.
  • 7Sharma S, Gupta DK. Gender assignment and hormonal treatment for disorders of sexual differentiation. Pediatr Surg Int, 2008, 24(10) :1131-1135.
  • 8Butler GE, Sellar RE, Walker RF, et al. Oral testosterone undecanoate in the management of delayed puberty in boys: pharmaeokineties and effects on sexual maturation and growth. J Clin Endocrinol Metab, 1992, 75 ( 1 ) :37-44.
  • 9Kshn FM, Schill WB. A new oral testosterone undecanoate ormulation. World J Urol, 2003, 21 (5) :311-315.
  • 10Feldman KW, Smith DW. Fetal phallic growth and penile standards for newborn male infants. J Pediatr, 1975, 86(3 ) : 395-398.

共引文献32

同被引文献59

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部